Event round-up: Quantum readiness: How can quantum unlock benefits in life sciences and drug discovery?
Recently techUK hosted the online webinar "How can quantum unlock benefits in life sciences and drug discovery?", bringing the wider tech community, the quantum sector, and the life sciences sector together to raise awareness as to the different ways that quantum and quantum-inspired solutions can enable future breakthroughs in science.
The event explored:
- Real-world quantum-based applications being used today and how researchers can leverage these tools
- Different proof of concepts, including faster identification and testing of potential drug compounds, reducing development timelines and costs.
- Support available in the UK from organisations such as the NQCC SPARQ programme
- Please note that techUK supports members across all quantum technologies. However, this event will primarily focus on quantum compute
Speakers included:
- Gopal Karemore, Global Quantum Lead in Healthcare & Life sciences, IBM Quantum
- Sonali Mohapatra, Quantum Innovation Sector Lead, National Quantum Computing Centre (NQCC)
- Vid Stojevic, CEO & Co-Founder, Kuano
- Bernadette Behnke, Commercialisation Lead, Life Sciences & Chemistry, Terra Quantum
You can watch the event here
What it techUK’s quantum readiness series?
As quantum technologies move from concept, development and towards deployment, it is critical that the UK’s leading industries and sectors are ready to realise the potential these new technologies can offer.
As such, techUK will be hosting a series of events and webinars showcasing how these technologies are starting to deliver impact across critical industries and sectors in the UK. We will spotlight real-world impact, emphasizing the imminent need for market readiness. You can view previous events in this series here.
Laura Foster
Laura is techUK’s Associate Director for Technology and Innovation.